Xylocaine - 63323-482-17 - (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE)

Alphabetical Index


Drug Information of Xylocaine

Product NDC: 63323-482
Proprietary Name: Xylocaine
Non Proprietary Name: LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE
Active Ingredient(s): .01; 10    mg/mL; mg/mL & nbsp;   LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE
Administration Route(s): INFILTRATION; PERINEURAL
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Xylocaine

Product NDC: 63323-482
Labeler Name: APP Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA006488
Marketing Category: NDA
Start Marketing Date: 20100812

Package Information of Xylocaine

Package NDC: 63323-482-17
Package Description: 25 VIAL, MULTI-DOSE in 1 CARTON (63323-482-17) > 10 mL in 1 VIAL, MULTI-DOSE

NDC Information of Xylocaine

NDC Code 63323-482-17
Proprietary Name Xylocaine
Package Description 25 VIAL, MULTI-DOSE in 1 CARTON (63323-482-17) > 10 mL in 1 VIAL, MULTI-DOSE
Product NDC 63323-482
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE
Dosage Form Name INJECTION, SOLUTION
Route Name INFILTRATION; PERINEURAL
Start Marketing Date 20100812
Marketing Category Name NDA
Labeler Name APP Pharmaceuticals, LLC
Substance Name EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
Strength Number .01; 10
Strength Unit mg/mL; mg/mL
Pharmaceutical Classes Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient]

Complete Information of Xylocaine


General Information